EUVIMEDEUVIMED entdecken
Crossref

Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension

Ya Luo iD, Xianmei Qi, Zhenxi Zhang, Jiawei Zhang iD, Bolun Li iD, Ting Shu iD, Xiaona Li, Huiyuan Hu, Jinqiu Li iD, Qihao Tang iD, Yitian Zhou iD, Mingyao Wang iD und 13 weitere

Circulation · 23.04.2024 · 149 (17) · 1354-1371

DOI: 10.1161/circulationaha.123.067579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 23.04.2024. Verfasst von Ya Luo und 24 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Health and Multimorbidity (Y.L., X.Q., J.Z., B.L., T.S., X.L., H.H., J.L., Q.T., Y.Z., J.P., P.Y., Y.X., J.W., C.…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Endothelial Cells, Malate Dehydrogenase. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary hypertension (PH) is a progressive cardiopulmonary disease with a high mortality rate. Although growing evidence has revealed the importance of dysregulated energetic metabolism in the pathogenesis of PH, the underlying cellular and molecular mechanisms are not fully understood. In this study, we focused on ME1 (malic enzyme 1), a key enzyme linking glycolysis to the tricarboxylic acid cycle. We aimed to determine the role and mechanistic action of ME1 in PH. METHODS: Global and endothelial-specific ME1 knockout mice were used to investigate the role of ME1 in hypoxia- and SU5416/hypoxia (SuHx)–induced PH. Small hairpin RNA and ME1 enzymatic inhibitor (ME1*) were used to study the mechanism of ME1 in pulmonary artery endothelial cells. Downstream key metabolic pathways and mediators of ME1 were identified by metabolomics analysis in vivo and ME1-mediated energetic alterations were examined by Seahorse metabolic analysis in vitro. The pharmacological effect of ME1* on PH treatment was evaluated in PH animal models induced by SuHx. RESULTS: We found that ME1 protein level and enzymatic activity were highly elevated in lung tissues of patients and mice with PH, primarily in vascular endothelial cells. Global knockout of ME1 protected mice from developing hypoxia- or SuHx-induced PH. Endothelial-specific ME1 deletion similarly attenuated pulmonary vascular remodeling and PH development in mice, suggesting a critical role of endothelial ME1 in PH. Mechanistic studies revealed that ME1 inhibition promoted downstream adenosine production and activated A 2A R-mediated adenosine signaling, which leads to an increase in nitric oxide generation and a decrease in proinflammatory molecule expression in endothelial cells. ME1 inhibition activated adenosine production in an ATP-dependent manner through regulating malate-aspartate NADH (nicotinamide adenine dinucleotide plus hydrogen) shuttle and thereby balancing oxidative phosphorylation and glycolysis. Pharmacological inactivation of ME1 attenuated the progression of PH in both preventive and therapeutic settings by promoting adenosine production in vivo. CONCLUSIONS: Our findings indicate that ME1 upregulation in endothelial cells plays a causative role in PH development by negatively regulating adenosine production and subsequently dysregulating endothelial functions. Our findings also suggest that ME1 may represent as a novel pharmacological target for upregulating protective adenosine signaling in PH therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryEndothelial CellsMalate DehydrogenaseAnimalsMice, KnockoutHumansMiceMice, Inbred C57BLPulmonary ArteryMaleCells, CulturedDisease Models, AnimalIndolesPyrroles

Stichwörter der Autor:innen

adenosineendothelial cellsenzymeshypertension, pulmonary

Substanzen

Malate Dehydrogenasemalate dehydrogenase (decarboxylating)SemaxinibIndolesPyrroles

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Health and Multimorbidity (Y.L., X.Q., J.Z., B.L., T.S., X.L., H.H., J.L., Q.T., Y.Z., J.P., P.Y., Y.X., J.W., C.W.).
  • Haihe Laboratory of Cell Ecosystem, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China (Y.L., X.Q., Z.Z., J.Z., B.L., T.S., X…
  • Department of Pulmonary and Critical Care Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing, China (Y.L.).
  • State Key Laboratory of Common Mechanism Research for Major Diseases (Z.Z., W.D.).
  • Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China (M.W., C.W.).
  • Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China (J.Z.).

ORCID-Profile: Ya Luo, Jiawei Zhang, Bolun Li, Ting Shu, Jinqiu Li, Qihao Tang, Yitian Zhou, Mingyao Wang, Jin Zhang, Peiran Yang, Chen Yan, Yanjiang Xing, Wenjing Du, Jing Wang

Zitieren

APA

Luo, Y., Qi, X., Zhang, Z., Zhang, J., Li, B., Shu, T., Li, X., Hu, H., Li, J., Tang, Q., Zhou, Y., Wang, M., Fan, T., Guo, W., Liu, Y., Zhang, J., Pang, J., Yang, P., Gao, R., …, & Wang, C. (2024). Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension. Circulation, 149(17), 1354-1371. https://doi.org/10.1161/circulationaha.123.067579

Vancouver

Luo Y, Qi X, Zhang Z, Zhang J, Li B, Shu T, et al. Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension. Circulation. 2024;149(17):1354-1371. doi:10.1161/circulationaha.123.067579

BibTeX
@article{Luo2024,
  author = {Luo, Ya and Qi, Xianmei and Zhang, Zhenxi and Zhang, Jiawei and Li, Bolun and Shu, Ting and Li, Xiaona and Hu, Huiyuan and Li, Jinqiu and Tang, Qihao and Zhou, Yitian and Wang, Mingyao and Fan, Tianfei and Guo, Wenjun and Liu, Ying and Zhang, Jin and Pang, Junling and Yang, Peiran and Gao, Ran and Chen, Wenhui and Yan, Chen and Xing, Yanjiang and Du, Wenjing and Wang, Jing and Wang, Chen},
  title = {Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension},
  journal = {Circulation},
  year = {2024},
  volume = {149},
  number = {17},
  pages = {1354--1371},
  doi = {10.1161/circulationaha.123.067579}
}
Kostenlos starten →